Medications for IgG4-Related Disease
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in IgG4-Related Disease.
Found 1 Approved Drug for IgG4-Related Disease
Uplizna
Generic Name
Inebilizumab
Uplizna
Generic Name
Inebilizumab
Form: Injection
Method of administration: Intravenous
FDA approval date: June 11, 2020
Classification: CD19-directed Cytolytic Antibody
UPLIZNA is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. UPLIZNA is a CD19-directed cytolytic antibody indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances